469 related articles for article (PubMed ID: 36829492)
1. Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence.
Granata V; Fusco R; De Muzio F; Cutolo C; Grassi F; Brunese MC; Simonetti I; Catalano O; Gabelloni M; Pradella S; Danti G; Flammia F; Borgheresi A; Agostini A; Bruno F; Palumbo P; Ottaiano A; Izzo F; Giovagnoni A; Barile A; Gandolfo N; Miele V
Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829492
[TBL] [Abstract][Full Text] [Related]
2. Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence.
Granata V; Fusco R; Setola SV; Galdiero R; Maggialetti N; Silvestro L; De Bellis M; Di Girolamo E; Grazzini G; Chiti G; Brunese MC; Belli A; Patrone R; Palaia R; Avallone A; Petrillo A; Izzo F
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672301
[TBL] [Abstract][Full Text] [Related]
3. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
[TBL] [Abstract][Full Text] [Related]
4. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
5. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret.
Zenouzi R; Liwinski T; Yamamura J; Weiler-Normann C; Sebode M; Keller S; Lohse AW; Schramm C;
Aliment Pharmacol Ther; 2018 Jul; 48(2):169-178. PubMed ID: 29741240
[TBL] [Abstract][Full Text] [Related]
6. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
Trilianos P; Selaru F; Li Z; Gurakar A
Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
[TBL] [Abstract][Full Text] [Related]
8. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Banales JM; Iñarrairaegui M; Arbelaiz A; Milkiewicz P; Muntané J; Muñoz-Bellvis L; La Casta A; Gonzalez LM; Arretxe E; Alonso C; Martínez-Arranz I; Lapitz A; Santos-Laso A; Avila MA; Martínez-Chantar ML; Bujanda L; Marin JJG; Sangro B; Macias RIR
Hepatology; 2019 Aug; 70(2):547-562. PubMed ID: 30325540
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis.
Satiya J; Mousa OY; Gupta K; Trivedi S; Oman SP; Wijarnpreecha K; Harnois DM; Corral JE
Clin Exp Hepatol; 2020 Feb; 6(1):35-41. PubMed ID: 32166122
[TBL] [Abstract][Full Text] [Related]
10. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.
Cazzagon N; El Mouhadi S; Vanderbecq Q; Ferreira C; Finnegan S; Lemoinne S; Corpechot C; Chazouillères O; Arrivé L
JHEP Rep; 2022 Nov; 4(11):100577. PubMed ID: 36277957
[TBL] [Abstract][Full Text] [Related]
11. Utility of MRCP in surveillance of primary sclerosing cholangitis associated hepatobiliary malignancy: 15 year experience at a single institution in Ontario, Canada.
Nair AV; Macdonald DB; Kelly EM; Satheesh S; Venugopalan P; Soman DK
Clin Imaging; 2022 Jan; 81():47-53. PubMed ID: 34598005
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing Biliary Strictures: Distinguishing IgG4-Related Sclerosing Cholangitis From Cholangiocarcinoma and Primary Sclerosing Cholangitis.
Hori Y; Chari ST; Tsuji Y; Takahashi N; Inoue D; Hart PA; Uehara T; Horibe M; Yamamoto S; Satou A; Zhang L; Notohara K; Naitoh I; Nakazawa T
Mayo Clin Proc Innov Qual Outcomes; 2021 Jun; 5(3):535-541. PubMed ID: 34195545
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis.
Rahnemai-Azar AA; Weisbrod A; Dillhoff M; Schmidt C; Pawlik TM
Surg Oncol; 2017 Jun; 26(2):125-137. PubMed ID: 28577718
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and surgical treatment of hepatic hilar cholangiocarcinoma.
Yang WL; Zhang XC; Zhang DW; Tong BF
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):631-5. PubMed ID: 18086631
[TBL] [Abstract][Full Text] [Related]
16. MR and MRCP in the evaluation of primary sclerosing cholangitis: current applications and imaging findings.
Elsayes KM; Oliveira EP; Narra VR; Abou El Abbass HA; Ahmed MI; Tongdee R; Brown JJ
J Comput Assist Tomogr; 2006; 30(3):398-404. PubMed ID: 16778613
[TBL] [Abstract][Full Text] [Related]
17. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
Bowlus CL; Lim JK; Lindor KD
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2416-2422. PubMed ID: 31306801
[TBL] [Abstract][Full Text] [Related]
18. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
